We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

600025:SSEHuaneng Lancang River Hydropower Co Ltd Class A Analysis

Data as of 2026-03-16 - not real-time

CN¥10.42

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Huaneng Lancang River Hydropower is trading at CNY 10.42, comfortably above its 20‑day (9.76), 50‑day (9.38) and 200‑day (9.51) moving averages, indicating short‑term bullish momentum. However, the RSI sits at 76, flagging an overbought condition, and the MACD histogram remains positive but modest, suggesting the upside may be limited in the near term.
Fundamentally, the stock’s PE ratio of 22.6 is slightly below the industry average of 23.3, offering a marginal valuation edge, yet the DCF‑derived fair value of only 3.65 implies a substantial overvaluation relative to intrinsic expectations. The company delivers a 1.9% dividend yield with a 43% payout ratio, but its balance sheet is stressed: a debt‑to‑equity of 143.6 and negative free cash flow raise questions about dividend sustainability.
Overall, the blend of strong operating margins (gross 57%, operating 54%) and stable utility cash flows provides a defensive cushion, while the high leverage, modest revenue growth (1.9%), and extreme market greed sentiment (Fear & Greed Index 78.4) heighten downside risk.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • RSI in overbought territory
  • Price near resistance at 10.66
  • Significant gap between market price and DCF fair value

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Stable dividend yield and payout ratio
  • Strong operating margins typical of utilities
  • Increasing trading volume supporting liquidity

Long Term

> 3 years
Cautious
Model confidence: 8/10

Key Factors

  • High debt‑to‑equity ratio and negative free cash flow
  • Limited revenue growth prospects
  • Potential regulatory shifts affecting renewable subsidies

Key Metrics & Analysis

Financial Health

Revenue Growth1.90%
Profit Margin32.99%
P/E Ratio22.7
ROE11.28%
ROA3.79%
Debt/Equity143.61
P/B Ratio2.8
Op. Cash FlowCN¥18.0B
Free Cash FlowCN¥-4366840320
Industry P/E23.3

Technical Analysis

TrendNeutral
RSI76.5
SupportCN¥9.00
ResistanceCN¥10.66
MA 20CN¥9.76
MA 50CN¥9.38
MA 200CN¥9.51
MACDBullish
VolumeIncreasing
Fear & Greed Index78.39

Valuation

Fair ValueCN¥3.65
GradeOvervalued
TypeValue
Dividend Yield1.91%

Risk Assessment

Beta-0.03
Volatility16.17%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.